rs73340816
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_016616.5(NME8):c.994+19A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00174 in 1,594,754 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0063 ( 5 hom., cov: 32)
Exomes 𝑓: 0.0013 ( 4 hom. )
Consequence
NME8
NM_016616.5 intron
NM_016616.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0270
Publications
1 publications found
Genes affected
NME8 (HGNC:16473): (NME/NM23 family member 8) This gene encodes a protein with an N-terminal thioredoxin domain and three C-terminal nucleoside diphosphate kinase (NDK) domains, but the NDK domains are thought to be catalytically inactive. The sea urchin ortholog of this gene encodes a component of sperm outer dynein arms, and the protein is implicated in ciliary function. Mutations in this gene are implicated in primary ciliary dyskinesia type 6.[provided by RefSeq, Nov 2009]
NME8 Gene-Disease associations (from GenCC):
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- primary ciliary dyskinesia 6Inheritance: AR Classification: LIMITED Submitted by: ClinGen, PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 7-37877026-A-G is Benign according to our data. Variant chr7-37877026-A-G is described in ClinVar as Benign. ClinVar VariationId is 260771.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00628 (956/152344) while in subpopulation AFR AF = 0.0177 (738/41586). AF 95% confidence interval is 0.0167. There are 5 homozygotes in GnomAd4. There are 485 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AR,AD gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| NME8 | NM_016616.5 | c.994+19A>G | intron_variant | Intron 12 of 17 | ENST00000199447.9 | NP_057700.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NME8 | ENST00000199447.9 | c.994+19A>G | intron_variant | Intron 12 of 17 | 1 | NM_016616.5 | ENSP00000199447.4 | |||
| NME8 | ENST00000440017.5 | c.994+19A>G | intron_variant | Intron 11 of 15 | 1 | ENSP00000397063.1 | ||||
| ENSG00000290149 | ENST00000476620.1 | c.-38+19681A>G | intron_variant | Intron 2 of 3 | 4 | ENSP00000425858.1 | ||||
| NME8 | ENST00000426106.1 | n.106-7277A>G | intron_variant | Intron 2 of 4 | 5 | ENSP00000408841.1 |
Frequencies
GnomAD3 genomes AF: 0.00628 AC: 956AN: 152226Hom.: 5 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
956
AN:
152226
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00239 AC: 596AN: 249070 AF XY: 0.00205 show subpopulations
GnomAD2 exomes
AF:
AC:
596
AN:
249070
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00126 AC: 1813AN: 1442410Hom.: 4 Cov.: 27 AF XY: 0.00123 AC XY: 886AN XY: 718946 show subpopulations
GnomAD4 exome
AF:
AC:
1813
AN:
1442410
Hom.:
Cov.:
27
AF XY:
AC XY:
886
AN XY:
718946
show subpopulations
African (AFR)
AF:
AC:
568
AN:
33028
American (AMR)
AF:
AC:
231
AN:
44626
Ashkenazi Jewish (ASJ)
AF:
AC:
10
AN:
25978
East Asian (EAS)
AF:
AC:
1
AN:
39368
South Asian (SAS)
AF:
AC:
10
AN:
85770
European-Finnish (FIN)
AF:
AC:
1
AN:
53318
Middle Eastern (MID)
AF:
AC:
40
AN:
5436
European-Non Finnish (NFE)
AF:
AC:
762
AN:
1095254
Other (OTH)
AF:
AC:
190
AN:
59632
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
84
168
251
335
419
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00628 AC: 956AN: 152344Hom.: 5 Cov.: 32 AF XY: 0.00651 AC XY: 485AN XY: 74498 show subpopulations
GnomAD4 genome
AF:
AC:
956
AN:
152344
Hom.:
Cov.:
32
AF XY:
AC XY:
485
AN XY:
74498
show subpopulations
African (AFR)
AF:
AC:
738
AN:
41586
American (AMR)
AF:
AC:
134
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5194
South Asian (SAS)
AF:
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
AC:
60
AN:
68026
Other (OTH)
AF:
AC:
19
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
54
108
161
215
269
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
8
AN:
3474
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Primary ciliary dyskinesia 6 Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.